#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thermal burn Gastric cancer Leiomyosarcoma recurrent Hypereosinophilic syndrome Immune thrombocytopenia Neuronal ceroid lipofuscinosis Nephroblastoma Cervix carcinoma recurrent Andersen-Tawil syndrome Urethral valves Myocarditis Adrenogenital syndrome Lennox-Gastaut syndrome Cerebellar ataxia Eosinophilic granulomatosis with polyangiitis More trials…

    Learn about Rare Diseases

    SAPHO syndrome – Life with Disease Epidermolysis bullosa – Trials in Disease Systemic mastocytosis – Diagnostics Medulloblastoma recurrent – Diagnostics Focal segmental glomerulosclerosis – Diagnostics Leiomyosarcoma metastatic – Basic Information Haemophilia B with anti factor IX – Trials in Disease Chondrosarcoma – Treatment Carcinoid syndrome – Treatment Congenital hypotransferrinaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Varegacestat Fosfomycin Oxybuprocaine Hydrochloride Faricimab Balcinrenone Levosimendan IDROXIOLEIC ACID Lumateperone Fitusiran Rct2100 Melphalan Flufenamide Mannitol Digoxin Immune Fab (Ovine) Diphenhydramine Hydrochloride Betula Verrucosa (108) Mps-215 Aspergillus Fumigatus Gedatolisib Navtemadlin Ulipristal Acetate More therapies…

    Learn about Your Condition

    Cushing's syndrome Psychogenic seizure Deafness neurosensory Lung transplant rejection Renal injury Cardiovascular disorder Renal cancer recurrent Pulmonary embolism Myeloid leukaemia Primary myelofibrosis Diabetic retinal oedema Acute promyelocytic leukaemia Ischaemic skin ulcer Lower limb fracture Aortic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bronchopulmonary dysplasia

  • A study on azithromycin for preventing airway infections in children aged 0-72 months with structural lung damage or congenital lung and airway malformations

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azithromycin
    Denmark

  • Study on the Effect of Caffeine Citrate for Patients with Extubation Failure and Bronchopulmonary Dysplasia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    • Infantile apnoea
    • Neonatal respiratory failure
    Investigated Drugs:
    • Caffeine Citrate
    Hungary

  • Safety Study of Mesenchymal Cells for Preterm Infants with Bronchopulmonary Dysplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Mesenchymal Cells
    Spain

  • Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies

    Recruiting

    4 1
    Investigated Drugs:
    • Recombinant Human Surfactant Protein-D
    Belgium Czechia France Germany Italy Poland +2

  • Study on the Safety and Effect of EXOB-001 in Preventing Bronchopulmonary Dysplasia in Extremely Preterm Newborns

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Allogeneic Umbilical Cord Mesenchymal Cells-Derived Extracellular Vesicles
    • Sodium Chloride
    Belgium Italy

  • Study on Mecasermin Rinfabate for Preventing Chronic Lung Disease in Extremely Premature Babies

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Mecasermin Rinfabate
    Finland Germany Ireland Italy The Netherlands Portugal +1
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!